131 related articles for article (PubMed ID: 32329069)
1. Development and validation of a novel epigenetic signature for predicting prognosis in colon cancer.
Luo D; Liu Q; Shan Z; Cai S; Li Q; Li X
J Cell Physiol; 2020 Nov; 235(11):8714-8723. PubMed ID: 32329069
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
[TBL] [Abstract][Full Text] [Related]
3. A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer.
Luo D; Shan Z; Liu Q; Cai S; Li Q; Li X
Biomed Res Int; 2020; 2020():4845360. PubMed ID: 33282950
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer.
Dai W; Feng Y; Mo S; Xiang W; Li Q; Wang R; Xu Y; Cai G
Carcinogenesis; 2018 Oct; 39(10):1235-1244. PubMed ID: 29982331
[TBL] [Abstract][Full Text] [Related]
5. A robust gene signature for the prediction of early relapse in stage I-III colon cancer.
Dai W; Li Y; Mo S; Feng Y; Zhang L; Xu Y; Li Q; Cai G
Mol Oncol; 2018 Apr; 12(4):463-475. PubMed ID: 29377588
[TBL] [Abstract][Full Text] [Related]
6. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
Xu G; Zhang M; Zhu H; Xu J
Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Jin Y; Wang L; Lou H; Song C; He X; Ding M
Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
[TBL] [Abstract][Full Text] [Related]
8. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
Wang J; He L; Tang Y; Li D; Yang Y; Zeng Z
Aging (Albany NY); 2020 Nov; 12(22):23200-23216. PubMed ID: 33221751
[TBL] [Abstract][Full Text] [Related]
12. An integrated mRNA-lncRNA signature for relapse prediction in laryngeal cancer.
Xiang Y; Li C; Liao Y; Wu J
J Cell Biochem; 2019 Sep; 120(9):15883-15890. PubMed ID: 31062433
[TBL] [Abstract][Full Text] [Related]
13. Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis.
Fang Z; Xu S; Xie Y; Yan W
World J Surg Oncol; 2021 Jan; 19(1):13. PubMed ID: 33441161
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer.
Ren J; Feng J; Song W; Wang C; Ge Y; Fu T
Clin Exp Med; 2020 Nov; 20(4):535-544. PubMed ID: 32772211
[TBL] [Abstract][Full Text] [Related]
16. A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis.
Lu Z; Chen J; Yan J; Liu Q; Li F; Xiong W; Lin S; Yu K; Liang J
Comb Chem High Throughput Screen; 2021; 24(8):1205-1216. PubMed ID: 32998675
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
[TBL] [Abstract][Full Text] [Related]
18. Identification of epigenetic genes for predicting prognosis and immunotherapy response of ovarian cancer.
Shen W; Jiang W; Ye S; Sun M; Yang H; Shan B
Jpn J Clin Oncol; 2022 Jul; 52(7):742-751. PubMed ID: 35435215
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice.
Liu J; Dong C; Jiang G; Lu X; Liu Y; Wu H
BMC Med Genomics; 2020 Sep; 13(Suppl 9):135. PubMed ID: 32957968
[TBL] [Abstract][Full Text] [Related]
20. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]